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The Wnt signaling pathway plays a role in the development of the central nervous
system and growing evidence indicates that Wnts also regulates the structure and
function of the adult nervous system. Wnt components are key regulators of a variety
of developmental processes, including embryonic patterning, cell speciﬁcation, and cell
polarity. In the nervous system, Wnt signaling also regulates the formation and function
of neuronal circuits by controlling neuronal differentiation, axon outgrowth and guidance,
dendrite development, synaptic function, and neuronal plasticity. Wnt factors can signal
through three very well characterized cascades: canonical or β-catenin pathway, planar
cell polarity pathway and calcium pathway that control different processes. However,
divergent downstream cascades have been identiﬁed to control neuronal morphogenesis.
In the nervous system, the expression of Wnt proteins is a highly controlled process.
In addition, deregulation of Wnt signaling has been associated with neurodegenerative
diseases. Here, we will review different aspects of neuronal and dendrite maturation,
including spinogenesis and synaptogenesis. Finally, the role ofWnt pathway components
on Alzheimer’s disease will be revised.
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INTRODUCTION
The development and speciﬁcation of different organs and tissues
that take place during embryonic development is tightly coor-
dinated by speciﬁc signaling molecules known as morphogens
including sonic hedgehog (Shh), transforming growth factor β
(TGF β), ﬁbroblast growth factor (FGF), and Wnt factors. These
ligands bind to speciﬁc receptors and activate intracellular cascades
that regulate different cellular processes and behavior (Tabata and
Takei, 2004).
Wnt factors are secretedmorphogens that regulate cell fate deci-
sion, cell polarity, and embryonic patterning (Parr and McMahon,
1994; Wodarz and Nusse, 1998; Nusse and Varmus, 2012). In the
last years, a great body of evidence has demonstrated that Wnt
signaling also plays a key role in the formation and modulation of
neuronal circuits. In the nervous system,Wntproteins are required
during development for early patterning by acting as posterioris-
ing signals, for neural crest cell induction, neural precursor, cell
proliferation, and neurogenesis (Ciani and Salinas, 2005; Toledo
et al., 2008). Moreover, Wnts regulate essential processes includ-
ing neuronal migration, neuronal polarization, axon guidance,
dendrite development, and synapse formation which are required
for a proper brain wiring (Ciani and Salinas, 2005; Inestrosa and
Arenas, 2010). Wnts are highly conserved molecules among ani-
mal species (van Amerongen and Nusse, 2009). Wnt proteins bind
to the amino-terminal cysteine-rich domain (CRD) of the seven
transmembrane Frizzled (Fz) receptors. In addition to Fz,Wnt lig-
ands can also signal through other receptors with tyrosine kinase
activity such as atypical receptor related tyrosine kinase (RYK)
and orphan receptor tyrosine kinase (ROR2) (Inoue et al., 2004;
Logan and Nusse, 2004). Interestingly, insulin-like growth factor 1
(IGF-1) receptor (IGF-1r) is emerging as a potential Wnt receptor
to modulate neuronal events (Hu et al., 2012). After Wnts bind to
their receptors, they activate a number of possible intracellular cas-
cades: theWnt–β-cateninpathway (canonical pathway), the planar
cell polarity pathway (PCP pathway) and the calcium pathway
(Figure 1). In the canonical pathway, the binding of theWnt ligand
to its Fz receptor and the low-density lipoprotein receptor-related
protein 5/6 (LRP5/6) activate the scaffolding protein Dishevelled
(Dvl), which in turn induces the disassembly of the complex
formed by axin, adenomatous polyposis coli (APC), and the ser-
ine/threonine kinase glycogen synthase kinase-3β (GSK-3β). In
the absence of Wnt signaling, β-catenin is synthesized but rapidly
degraded due the phosphorylation by GSK-3β (Orford et al., 1997;
Salic et al., 2000). In the presence of Wnt,GSK-3β is inhibited lead-
ing to the accumulation and the stabilization of β-catenin in the
cytosol and its translocation into the nucleus, where it associates
with the transcription factor TCF (T cell factor)/LEF (lymphoid
enhancing factor) to regulateWnt target genes (Gordon andNusse,
2006). In the PCP pathway,Wnt binds to its receptor and activates
Dvl which leads to changes in both actin and microtubule reor-
ganization. These alterations involve the activation of the small
Rho-GTPases proteins and c-Jun-N-terminal kinase (JNK; Rosso
et al., 2005; Gordon and Nusse, 2006). Finally, in the calcium
pathway, Wnt increases the intracellular level of Ca2+ leading
to the activation of calcium sensitive kinases such as protein
kinase C (PKC) and Ca2+/calmodulin-dependent protein kinase
II (CamKII) and the nuclear translocation of the transcription
factor nuclear factor of activated T cells (NFACT).
Importantly, the same ligand can function through different
Wnt pathway depending on the receptor and cellular context.
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FIGURE 1 |The main branches ofWnt signalling pathways in neuronal
development.Wnt factors bind to their classical receptor Frizzleds (Fz) or
interact with tyrosine kinase receptors such as RYK, ROR2, and also IGF1R
depending on the cellular context. In the canonical or WNT/β-catenin pathway
Wnt also interacts with the LRP5/6 co-receptor and activates Dvl that
contains three domains involving in different neuronal functions. Activation of
Dvl mainly results in the GSK3β inhibition and the β-catenin accumulation in
the cytosol which translocates to the nucleus where it activates speciﬁc gene
transcription. Divergent pathways have been shown to control axon and
dendrite morphology and presynaptic function. In the planar cell polarity (PCP)
pathway Wnt binds to Fz and activates Dvl, which in turns signals to small
Rho-GTPases proteins. Activation of Rac induces changes in the activity of
JNK leading to changes in the cytoskeleton. This cascade was implied in
dendrite development and complexity. In the Wnt/calcium pathway, activation
of Dvl induces the increase of intracellular level of calcium and activation of
PKC and CamKII affecting the transcription of NF-AT nuclear factor. However,
divergent cascades involving the activation of CamKII have been identiﬁed to
modulate neuronal polarity, dendritic spines morphology and synapses.
In this review, we will discuss the role of Wnt proteins during
neuronal development and maturation. Firstly, we will describe
the Wnts function during initial neuronal differentiation and
axon behavior. Then, we will focus on the role of Wnt factors
on neuronal maturation particularly the formation of dendritic
arbors and their function as modulators of synaptic physiology.
Finally, we will concentrate on the preventive role of Wnt sig-
naling on neurodegenerative diseases in particular Alzheimer’s
disease (AD).
Wnt SIGNALING AND NEURONAL DEVELOPMENT
Wnt REGULATE AXON OUTGROWTH AND MORPHOLOGY
The proper function of the nervous system depends on the
morphological complexity of the neurons, the participation of
non-neuronal cells and the establishment of suitable neuronal
connections. Neurons are highly polarized cells that ensure an
unidirectional ﬂow of information. After they are born, neurons
differentiate and establish two compartments: axon and den-
drites which have distinct molecular composition, morphology
and functioning (see Dotti et al., 1988). This polarized arrange-
ment is fundamental for neuronal function in order to receive and
propagate electrical signals to distinct sites.
A very useful system for studying neuronal polarization and
axon growth is the cultured hippocampal neurons, which displays
ﬁve developmental stages. Firstly, neurons elaborate lamellipodia
(stage 1) and then, short neurites or minor processes (stage 2).
After that, one of these neurites grows faster and becomes the axon
with a large and highly dynamic growth cone (stage 3), leaving the
rest of the neurites to form dendrites (stage 4). Finally, dendrite
maturation takes place and very complex dendritic arbors are able
to initiate synaptic function (stage 5; Dotti et al., 1988; Craig and
Banker, 1994).
Neuronal polarization and maturation are controlled not only
by intrinsic factors and genes expression programs but also by
moleculeswhich come from the extracellularmatrix. These extrin-
sic molecules are potential regulators for axon speciﬁcation and
pathﬁnding, neuronal maturation and synapses formation and
maintenance. Among these molecules there are neurotrophic
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factors such as nerve growth factor (NGF), brain-derived neu-
rotrophic factor (BDNF), and neurotrophin 3 (NT3) which
function as neuronal polarity and axon development modula-
tors through the activation of tyrosine receptor kinases (Trks;
Huang and Reichardt, 2003). However, another family of extra-
cellular factors called Wnt proteins is emerging as a regulator of
initial axon differentiation, growth and axonal behavior. Inter-
estingly, Wnt5a is required for NGF-dependent axonal branching
and growth (Bodmer et al., 2009). Wnt5a would function as a
key NGF downstream effector in developing sympathetic neurons
by locally activation of PKC (Bodmer et al., 2009). In addition,
NGF enhances the expression of Wnt5a in sympathetic neurons.
Furthermore, Wnt5a-null mice neurons show deﬁcits in NGF-
dependent axonal development (Bodmer et al., 2009). Another
study carried out in Drosophila demonstrates that Wnt5a func-
tions as a ligand in the PCP pathway during axonal growth and
branching (Shimizu et al., 2011). Importantly, other PCP path-
way components such as Fz, strabismus, ﬂamingo, and disheveled
are cooperatively required for axonal targeting and branching.
Authors propose that Wnt5a and the PCP pathway regulate
axonal development in Drosophila neurons carefully (Shimizu
et al., 2011).
Disheveled is the ﬁrst downstream effector of Wnt signaling
pathways. Many studies have demonstrated that Dvl is a neurite
growth and differentiation key regulator. Dvl expression in neu-
roblastoma 2A cell (N2A cells) promotes neurite outgrowth and
induces N2A cells differentiation (Fan et al., 2004). This neuronal
remodeling depends on a Dvl N-terminal DVL domain (DIX).
The DIX domain is essential for the Dvl effect on neuronally
differentiating N2A cells (Fan et al., 2004). Accordingly, other
studies have shown that Dvl regulates neurite extension through
the microtubule stability regulation. Dvl colocalizes with axonal
microtubules and protects stable microtubules from nocodazole
depolymerization (Krylova et al., 2000; Rosso et al., 2005). Dvl
increases microtubule stability through GSK-3β inhibition and
changes in the microtubule-associated protein 1B (MAP1B) activ-
ity (Ciani et al., 2004). Additionally, another work reveals that
Dvl promotes axon differentiation by regulating atypical PKC
(aPKC; Zhang et al., 2007). In cultured hippocampal neurons
aPKC is directly regulated by Dvl. Thus, Dvl downregulation abol-
ishes axon differentiation. In contrast, Dvl overexpression induces
multiple axons formation (Zhang et al., 2007). Interestingly, the
authors show that Dvl associates and activates aPKC in these neu-
rons and the expression of a aPKC dominant negative prevents
the Dvl multiple axons formation (Zhang et al., 2007). To add,
Dvl forms a complex with PAR3, PAR6, and aPKC, resulting in
aPKC stabilization and activation. Furthermore, treatment with
Wnt5a, a non-canonical Wnt factor, induces the aPKC activation
and promotes axon differentiation in cultured hippocampal neu-
rons (Zhang et al., 2007). These evidences demonstrate the Wnt
pathways participation on the initial neuronal differentiation.
Several Wnt signaling effectors are very well known as axonal
modulators, such as GSK3β and APC belonging to the canoni-
cal pathway and the small Rho-GTPases proteins and associated
kinases from the PCP pathway. Many proteins regulate the
cytoskeleton dynamics and organization functioning as direct tar-
gets of GSK-3β. For example, microtubule-associated proteins
(MAPs), such as MAP1B, tau, and MAP2, which are expressed in
developing neurons, function asmicrotubule stabilizers and canbe
phosphorylated byGSK-3β (Berling et al., 1994; Lucas et al., 1998).
Another protein that is directly phosphorylated by GSK-3β is APC,
an important player in the Wnt signaling pathway and a micro-
tubule plus-end binding protein that is accumulated at growth
cones (Zumbrunn et al., 2001; Zhou et al., 2004). Phosphoryla-
tion of these proteins by GSK-3β changes their ability to bind
microtubules and their function as modulators of microtubule
dynamics (Gonzalez-Billault et al., 2004; Zhou et al., 2004; Baas
and Qiang, 2005). Thus, changes in the cytoskeletal proteins phos-
phorylation might contribute to axon determination and growth.
In addition, it has been observed that cultured neurons exposed
to Wnts elicits an axonal remodeling, a process characterized by
axonal spreading and growth cone enlargement (Hall et al., 2000;
Krylova et al., 2002). In the presence of Wnt, microtubules form
loops as observed in axonal growth cones of granule cells (Hall
et al., 2000). Thismicrotubule reorganization is likely to determine
changes in axon behavior. Importantly, loss of Wnt7a or its effec-
tor DVL causes severe defects in the terminal remodeling of axons
in vivo (Ahmad-Annuar et al., 2006; Hall et al., 2000). Accord-
ing to this evidence, another later study showed that exposure to
Wnt3a decreases the speed of growth cone advance whilst increas-
ing growth cone size (Purro et al., 2008). The authors propose
that Wnt regulates axon behavior through changes in microtubule
growth directionality induced by a decrease in the APC level on
microtubule plus-ends (Purro et al., 2008).
Taken together, these data clearly demonstrate that Wnt factors
and their effectors positivelymodulate axonoutgrowth andgrowth
cone behavior through changes in the cytoskeletal components
activity affecting their organization and stability.
Wnt PROTEINS CONTROL DENDRITIC MORPHOGENESIS
A mature neuron elicits a clear architecture characterized by a
long distally branched axon which transmits signals, and a very
complex dendritic arbor which is specialized to collect and inte-
grate signals. Appropriate connections within the nervous system
require the establishment of a polarized morphology to ensure
unidirectional signal propagation (Jan and Jan, 2003; Conde and
Caceres, 2009). Although a proper dendrite remodeling and shape
underlies the normal mammalian brain function, including cog-
nition and memory formation, abnormal dendritic development
closely correlates with mental retardation and a number of cen-
tral nervous system (CNS) disorders including Down’s, Rett, and
Fragile X syndromes (Comery et al., 1997; Kaufmann and Moser,
2000; Miller and Kaplan, 2003; De Rubeis and Bagni, 2010).
The molecular and cellular mechanisms that regulate dendritic
growth and reﬁnement are an area of intense research. Each neu-
ron acquires its precise dendritic pattern through the regulation
of its cytoskeleton by activating signaling pathways that change
the activity, localization, and stability of cytoskeletal regulators
(Conde and Caceres, 2009). Dendrite growth is a very dynamic
process and the pattern of dendritic trees is believed to be regulated
by an interplay between an intrinsic genetic program, extrinsic
factors, and neuronal activity (Cline, 2001; Scott and Luo, 2001;
Whitford et al., 2002a; Jan and Jan, 2003). Many extracellular fac-
tors have been identiﬁed as regulators of dendritic growth and
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branching. For example, in vertebrates NT3, BDNF, and NGF
can function as extrinsic factors to modulate the neuronal den-
driticmorphology (McAllister et al., 1995). Furthermore, the same
neurotrophic factor can either inhibit or promote dendritic out-
growth depending on the type of neuron (McAllister et al., 1997).
Semaphorin-3A (Sema3A) acts through the neuropilin-1 receptor,
functions as chemoattractant factor for growing apical dendrites
whereas antibody against neuropilin-1 can attenuate this dendrite
orientation (Polleux et al., 2000). Consistent with this notion, in
Sema3A null mice, many of the cortical pyramidal neurons have
misoriented apical dendrites. Several evidences have shown that
other extracellular factors such as Notch1 and Slit1 also regulate
the emergence and growth of basal dendrites (Threadgill et al.,
1997; Redmond et al., 2000; Whitford et al., 2002b). In addition,
bone morphogenetic protein 7 (BMP7), a member of the TGF-β
superfamily of ligands that are crucial for nervous system devel-
opment, also affect dendritic morphogenesis in cultured neurons
(Whitford et al., 2002a; Miller and Kaplan, 2003; Podkowa et al.,
2010).
Another family of proteins that have been extensively involved
in dendrite formation, maintenance, and functioning during
the last decade is Wnt proteins. Several evidences suggest that
Wnt factors modulate axon morphology and branching prob-
ably because they affect the activity and localization of many
cytoskeletal regulators. These ﬁndings lead to consider that Wnt
signalingmay also regulate the dendritic treesmorphology. Several
studies have shown that Wnt proteins regulate dendritic architec-
ture through the activation of different cascades. In this context,
Yu and Malenka (2003) have postulated to β-catenin as a criti-
cal mediator of dendritic morphology. Thus, overexpression of
β-catenin increases dendritic arborization in hippocampal neu-
rons through a non-transcriptional mechanism (Yu and Malenka,
2003). Instead, constitutively active β-catenin increases dendritic
arborization through its interaction with N-cadherin and αN-
catenin (neural-catenin). Conversely, sequestering endogenous
β-catenin leads to a decrease in dendritic complexity caused by
neural activity (high K+ depolarization) suggesting that the level
of endogenous β-catenin is important to the regulation of den-
dritic branching (Yu and Malenka, 2003). In addition, dickkopf-1
(Dkk-1), an extracellular Wnt antagonist (Glinka et al., 1998),
blocks the dendritogenic effect of depolarization by high K+
suggesting that neuronal activity regulates Wnt expression or
release, which in turn modulates dendritic arborization. Impor-
tantly, conditioned medium from depolarized neurons contain
higher levels of Wnt than does media from non-stimulated cells
(Yu and Malenka, 2003). Another study showed that neuronal
activity enhances the expression of Wnt-2, which stimulates den-
dritic complexity in cultured hippocampal neurons (Wayman
et al., 2006). Activity-dependent dendritic outgrowth and branch-
ing in cultured neurons and slices is mediated through activation
of Ca+2 depending signaling pathway (Wayman et al., 2006). In
agreement with these studies, it has been demonstrated that Wnt
signaling through Dvl stimulates dendritic growth and branch-
ing in hippocampal neurons (Rosso et al., 2005). Particularly,
Wnt7b which is expressed in the hippocampus during dendri-
togenesis increases dendritic arborization by increasing dendritic
length and the formation of complex branches. This effect is
blocked by a Wnt scavenger, Sfrp1 (soluble Fz-related protein-
1). Sfrp1 blocks endogenous Wnt activity present in hippocampal
cultures that contributes to the normal dendritic development
(Rosso et al., 2005). The Wnt effect on dendrite development is
mimicked by Dvl that localizes along the neurites associated with
microtubules and is highly concentrated in the peripheral region
of growth cones co-localizing with actin cytoskeleton (Rosso
et al., 2005; Figure 2). Dvl1 mutant neurons exhibit shorter and
less complex dendrite arbors compared to neurons from wild-
type mice (Rosso et al., 2005). These results demonstrate that
Dvl1 is required for normal dendritic development in hippocam-
pal neuron (Rosso et al., 2005). Further analyses revealed that
Wnt7b/Dvl signaling regulates dendritic development through a
non-canonical pathway, since activation of GSK-3β or inhibition
of β-catenin is not involved. In contrast, Wnt7b and Dvl mod-
ulate dendrite development through changes in the activity of
Rho GTPases and JNK. Wnt7b and Dvl activate endogenous Rac
and its downstream effector JNK, this effect is abolished by Sfrp1.
FIGURE 2 |Wnt-Dvl pathway modulates dendrite development. (A,B)
EGFP expressing hippocampal neurons of 3 days in vitro (DIV) expose to
Wnt7b conditioned medium (WCM) show longer and more complex
dendritic arborizations compare to EGFP-control cells (CCM). Neurons are
staining with GFP antibody to analyze the entire morphology. (C–F): DVL
mimics the dendritogenic effect ofWnt7b. EGFP expressing neurons of 3
DIV develop several short and unbranched dendrites (MAP2+) (C,E).
However, hippocampal neurons expressing HA-DVL reveal very complex
dendritic trees with longer and more number of dendritic branches
(MAP2+) (D,F).
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Moreover, inhibition of JNK or expression of a Rac dominant
negative mutant in neurons blocks the Dvl function in den-
dritic development. These ﬁnding suggested that Dvl functions
as a molecular link between Wnt factors and the cytoskele-
tal modulators Rho GTPases to control dendritic development
(Rosso et al., 2005). In addition, a recent study shows that the
non-canonical Wnt signaling is necessary for normal morpho-
logical maturation of olfactory bulb (OB) interneurons (Pino
et al., 2011). Interestingly, traditionally non-canonical Wnt lig-
ands Wnt5a and Wnt7b, but not canonical Wnts, are expressed
by OB interneurons themselves (Shimogori et al., 2004). More-
over, evidence from the Wnt5a knockout mouse indicates that
normal morphological development of OB interneurons is dis-
rupted in the absence of endogenous Wnt5a, while cell number
and OB architecture remain intact (Pino et al., 2011). These data
are in accordance with those in hippocampal neurons where
Sfrp1 blocks neurite outgrowth and non-canonical Wnt ligand
Wnt7b increases dendrite complexity (Rosso et al., 2005; Endo
et al., 2008).
The role of Wnt ligands on neuronal maturation have also
been described in another model, such as C. elegans in which ﬁve
Wnts were identiﬁed (Park and Shen, 2012). A recent study in C.
elegans shows that dendrite outgrowth can be regulated by distinct
processes which are independent of axon formation (Kirszenblat
et al., 2011). This work suggests that the Wnt ligand (LIN-44), and
its Fz receptor (LIN-17), regulate dendrite development of the
oxygen sensory neurons (PQR) (Kirszenblat et al., 2011). In lin-44
and lin-17 mutants, neurons show a delayed growth. Additional
experiment revealed that LIN-44 functions as an attractive cue
to deﬁne the outgrowth of the dendrite (Kirszenblat et al., 2011).
LIN-44 acts at very early stages of PQR development by regulating
proper formation of the growth cone and its extension.
Taken together, these evidences reveal the important role
for Wnt signaling pathways in regulating dendrite develop-
ment and complexity and how Wnt expression and secretion
may be inﬂuenced by extracellular cues to modulate neuronal
morphogenesis.
Wnt SIGNALING AT CENTRAL SYNAPSES
Wnt ligands have been linked to the assembly of structural com-
ponents in presynaptic compartments. In the cerebellum, Wnt7a
is expressed in granular cells at the same time as the mossy
ﬁber axon, which is the presynaptic contact (Hall et al., 2000).
Several changes remodel the connectivity between both areas to
increase the contact surface. Wnt7a induces axonal spreading and
incremental growth of cone size and branching, leading to the
accumulation of synaptic proteins (Hall et al., 2000; Budnik and
Salinas, 2011). Wnt7a probably contributes to the formation of
active zones because it increases the clustering of synapsin I, a
protein located in the presynaptic membrane involved in synapse
formation and function (Hall et al., 2000). This effect has been
blocked by the Wnt scavenger Sfrp and a mutant mice deﬁ-
cient in Wnt7a shows a delayed synaptic maturation (Hall et al.,
2000). Then in the cerebellum, Wnt7a can act as a retrograde
signal from granular cells to induce presynaptic differentiation
in mossy ﬁber, working as a synaptogenic factor (Hall et al.,
2000; Ahmad-Annuar et al., 2006). Like Wnt7a, Wnt7b, and
Wnt3a increase the number of presynaptic puncta suggesting a
role for these ligands in presynaptic assembly (Ahmad-Annuar
et al., 2006; Cerpa et al., 2008; Davis et al., 2008). Wnt7a also
increases the clustering of presynaptic proteins such as synap-
tophysin, synaptotagmin, and synaptic vesicle protein 2 (SV2),
but does not affect postsynaptic clustering of proteins like post-
synaptic density protein-95 (PSD-95; Cerpa et al., 2008). Despite
Wnt7a clustering induction correlates with β-catenin stabiliza-
tion, this does not involve Wnt gene target expression – an
effect that is also mimicked by Wnt3a. Unexpectedly, GSK-
3β is also not required for presynaptic clustering induced by
Wnt7a, suggesting that an upstreammechanism is involved (Cerpa
et al., 2008). It has been suggested that Wnt7a requires Dvl1 to
mediate the normal recycling rate of synaptic vesicles, and the
deﬁciency of both proteins (double null mutant) signiﬁcantly
reduces miniature exitatory postsynaptic current (mEPSCs) fre-
quency, an indication of a defect in neurotransmitter release
(Ahmad-Annuar et al., 2006). Additionally, the use of FM dyes
has shown that Wnt7a stimulates recycling and accelerates exo-
cytosis of synaptic vesicles (Ahmad-Annuar et al., 2006; Cerpa
et al., 2008). Moreover,Wnt7a increases the frequency of mEPSCs,
suggesting that Wnt7a increases the dynamic of neurotrans-
mitter release (Ahmad-Annuar et al., 2006; Cerpa et al., 2008).
Furthermore, Wnt7a/Dvl1 double mutant mice exhibit reduced
mEPSC frequency at the mossy ﬁber-granule cell synapses, reveal-
ing a defect in neurotransmitter release as a consequence of
this mutation (Ahmad-Annuar et al., 2006). Electrophysiologi-
cal recordings on hippocampal rat slices also show that, in the
CA3–CA1 synapseWnt7a, but notWnt5a, increases the amplitude
of ﬁeld excitatory postsynaptic potentials (fEPSP) and decreases
the rate of paired pulse facilitation (PPF; Cerpa et al., 2008),
a protocol used to distinguish the involvement of the presy-
naptic from the postsynaptic terminal. In addition, a similar
modulation has been shown with nanomolar concentrations of
Wnt3a, which modulates the recycling and exocytosis of synap-
tic vesicles in hippocampal synapses, increasing the frequency
of mEPSC through a mechanism that involves Ca2+ entrance
from extracellular media (Cerpa et al., 2008; Avila et al., 2010).
Most of the ligands that are able to modulate presynaptic dif-
ferentiation have shown to activate the Wnt/β-catenin signaling
pathway.
Wnt7a has been also involved in trafﬁcking of receptors,
increasing the number and size of co-clusters of presynaptic
α7-nicotinic acetylcholine receptors (α7-nAChR) and APC in hip-
pocampal neurons, as well as in the modulation of the α7-nAChR
trafﬁcking to thenerve terminal (Farias et al., 2007), indicating that
Wnt pathway components are actively involved in the functional
availability of receptors in the synaptic terminal.
Wnt signaling also plays relevant roles in the postsynaptic
structure. Wnt5a induced a transient formation of dendritic
protrusions, which results in a net increase of mature dendrite
spines. Video microscopy revealed that Wnt5a induced de novo
formation of dendrite spines and also increased the size of the
preexistent ones (Varela-Nallar et al., 2010). Interestingly, treat-
ment with the soluble CRD region of Fz2, which act as a Wnt
scavenger, decreases spine density in cultured neurons, sup-
porting the idea that Wnt ligands participate in dendrite spine
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morphogenesis (Varela-Nallar et al., 2010). Wnt5a also induces
an increase of calcium in synaptic puncta of neurons, suggest-
ing the activation of the Wnt/Ca2+ signaling pathway in cultured
hippocampal neurons through a mechanism that involves fast
phosphorylation of CamKII induced by Wnt5a (Varela-Nallar
et al., 2010), as we demonstrated previously (Farias et al., 2009).
Wnt7a is also able to increase the density and maturity of den-
dritic spines through a CamKII-dependent mechanism (Ciani
et al., 2011). Wnt7a rapidly activates CamKII in spines and inhibi-
tion of this kinase abolishes the effects of Wnt7a on spine growth
and excitatory synaptic strength. These ﬁndings implicate the
Wnt/Ca2+ signaling cascade in synaptic effects of Wnt ligands
(Figure 3).
Interestingly, Dvl expressed only in postsynaptic spines and not
in innervating presynaptic axons is enough to induce spine growth,
suggesting that it is the activation of postsynaptic Wnt signaling
which induces spine maturation (Ciani et al., 2011). Moreover,
Dvl promotes the assembly of pre- and postsynaptic structures at
pre-existing spines because this does not change the number of
spines (Ciani et al., 2011). This evidence supports the idea that
an extracellular signal such as Wnt7a can generate a divergent
FIGURE 3 |Wnts modulate both pre- and postsynaptic regions of
central synapses affecting synaptic wiring and plasticity.The ﬁgure
indicates a central synapse of the mammalian nervous system. At the
presynaptic region, canonicalWnt7a ligand activates Fz receptor associated
to LRP5/6, and triggers the activation of the synaptic vesicle cycle, which
determines the release of the neurotransmitter glutamate. At the
postsynaptic level, Wnt5a ligand activates both theWnt/PCP (JNK) and the
Wnt/Ca signaling pathways, through activation of JNK,Wnt5a regulates the
clustering of PSD-95.Wnt5a also activates both non-canonical pathways
that allow an increase in the trafﬁc of NMDA receptors.
intracellular product, using a common molecule such as Dvl to
support processes like synaptic differentiation (Gao and Chen,
2010), and a new role for Wnt7a inducing the formation and
function of excitatory synapses through CamKII (Figure 3).
Wnt5a modulates postsynaptic assembly increasing the clus-
tering of the PSD-95 via Wnt/JNK signaling pathway (Farias et al.,
2009), inducing a fast increase in the number of PSD-95 clus-
ters without affecting total levels of PSD-95 protein or presynaptic
protein clustering in hippocampal cultured neurons (Farias et al.,
2009; Figure 3). PSD-95 is a scaffold protein of the postsynap-
tic density, which is a multiprotein complex that interacts with
key molecules involved in the regulation of glutamate receptor
targeting and trafﬁcking and regulatory proteins relevant for neu-
rotransmission (HanandKim,2008).Whenhippocampal neurons
were incubated with the formylated hexapeptide Foxy-5, derived
from the sequence of Wnt5a and mimics the full Wnt5a action,
there was an increase in PSD-95 since 1 h, but after 24 h an increase
in the SV2 clustering was also observed. In consequence, there was
an increase in the total number of synaptic contacts (Varela-Nallar
et al., 2012).
At the neuromuscular junction of vertebrate skeletal mus-
cles, Wnt3 was also able to induce recruitment of AChRs
(Henriquez et al., 2008). This effect requires Dvl1 and agrin, a
protoglycan released by motoneurons, but does not involve the
Wnt/β-catenin pathway. Instead, aggregation is induced through
activation of Rac1 (Henriquez et al., 2008). However, Wnt3a
inhibits agrin-induced AChR clusters through the activation of
theWnt/β-catenin pathway, suggesting thatWnt signaling dynam-
ically regulates the interaction between postsynaptic components
during the establishment of neuromuscular junctions (Wang et al.,
2008).
Different Wnts have shown modulatory effects on glutamater-
gic neurotransmission. Wnt3a modulates the recycling of synaptic
vesicles in hippocampal synapses (Cerpa et al., 2008; Varela-Nallar
et al., 2009) and is able to induce an increase in the frequency
of mEPSCs (Avila et al., 2010). In hippocampal slices, blockade
of Wnt signaling impairs long-term potentiation (LTP), whereas
activation of Wnt signaling facilitates LTP (Chen et al., 2006).
In the case of Wnt5a, acute application of this ligand in hip-
pocampal slices increases the amplitude of fEPSP and upregulates
synaptic N-methyl-D-aspartate (NMDA) receptor currents facil-
itating induction of LTP (Cerpa et al., 2010, 2011; Varela-Nallar
et al., 2010). Interestingly, Wnt5a produced a two-step increase
in the amplitude of NMDA receptor responses, not α-amino-
3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors
(Cerpa et al., 2011). There is a fast PKC-dependent potentiation
and a slower JNK-dependent potentiation that does not require
previous activation of PKC (Cerpa et al., 2011).
Wnt5a also regulates postsynaptically the hippocampal
inhibitory synapses (Cuitino et al., 2010). Wnt5a induces surface
expression and maintenance of GABAA receptor in the membrane
of hippocampal neurons, increases the amplitude of gamma-
aminobutyric acid (GABA)-currents due to postsynaptic mech-
anisms, and induces the recycling of functional GABAA receptors
through activation of CamKII (Cuitino et al., 2010). Therefore
Wnt5a is able tomodulate both, excitatory and inhibitory synapses
which must be relevant for neurotransmission.
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ROLE OF Wnt SIGNALING IN ALZHEIMER’S DISEASE
Major neurological diseases are all progressive disorders with com-
mon symptoms: a range of neuropsychiatric features, massive
neuronal degeneration, and neither preventive nor effective long-
term treatment strategies available. However, all of them develop
in particular brain regions generating a speciﬁc phenotype accord-
ing to the circuit that is being affected. Here, we review recent
studies related to the progression of AD in which the Wnt sig-
naling pathway and its components might be relevant. AD is a
neurodegenerative disorder characterized by progressive deterio-
ration of cognitive functions, caused by synaptic dysfunction and
damage of speciﬁc brain regions (Mattson, 2004; Toledo et al.,
2008). Distinctive features of AD brains are the presence of senile
plaques, composed by extracellular deposits of amyloid-β (Aβ)
peptides and neuroﬁbrillary tangles (NFTs), composed by intra-
cellular aggregates of hyper-phosphorylated tau protein (Mayeux
and Stern, 2012). Oligomeric forms of Aβ1−42 are the physiolog-
ically relevant neurotoxic Aβ species and Aβ oligomers isolated
from AD brains can damage the memory and alter hippocam-
pal synaptic plasticity in healthy rats, inhibiting LTP, increasing
long-term depression and reducing spine density in the hip-
pocampus in vivo (Shankar et al., 2007). The presence of Aβ
oligomers reduces the fEPSP and EPSCs, but not the PPF in
the CA3–CA1 synapse of rat hippocampal slices (Cerpa et al.,
2010; Inestrosa et al., 2012). Altogether these evidences sug-
gest that AD cognitive decline might be due to a direct effect
of Aβ oligomers on synaptic transmission (Palop and Mucke,
2010).
During more than a decade, a strong relationship between an
impaired Wnt signaling pathway activity and neuronal damage
in AD has been raised (De Ferrari and Inestrosa, 2000; Inestrosa
et al., 2000; Garrido et al., 2002; De Ferrari et al., 2003; Inestrosa
and Arenas, 2010). Different studies have shown that Wnt signal-
ing components are altered in AD (Zhang et al., 1998; Inestrosa
et al., 2002; Caricasole et al., 2004; Ghanevati and Miller, 2005; De
Ferrari et al., 2007; Magdesian et al., 2008). Among the Wnt com-
ponents that are affected in AD, it was shown that β-catenin levels
are reduced in AD patients carrying presenilin-1-inherited muta-
tions (Zhang et al., 1998), while the secreted Wnt antagonist Dkk1
is elevated in postmortem AD brains and brains from transgenic
mouse models for AD (Caricasole et al., 2004; Rosi et al., 2010).
A variant of the LRP6 has been associated with late-onset AD,
which confers low levels of Wnt signaling (De Ferrari et al., 2007).
Epidemiological data show an increased risk for AD in popula-
tions where the allele 4 of apo-lipoprotein E (apoE4) is present.
Interestingly apoE4 causes inhibition of the canonical Wnt sig-
naling in PC12 cells upon stimulation with Wnt7a as determined
by luciferase activities and nuclear β-catenin levels (Caruso et al.,
2006). A direct Aβ binding to the extracellular CRD-Fz5 recep-
tor at or in close proximity to the Wnt-binding site inhibits the
canonical Wnt signaling pathway (Magdesian et al., 2008), link-
ing directly Aβ to Wnt impairment. Moreover, the exposure of
cultured rat hippocampal neurons to Aβ results in inhibition
of canonical Wnt signaling as determined by destabilization of
endogenous levels of β-catenin, increase in GSK-3β activity, and
a decrease in the expression of some Wnt target genes (Alvarez
et al., 2004). Chronic overexpression of Dkk-1 causes age-related
tau phosphorylation and cognitive deﬁcits (Killick et al., 2012).
During Aβ exposure there is induction of Dkk-1 expression that
depends on p53 (Killick et al., 2012). This generated Dkk-1 can
bind LRP5/6 to inhibit their interaction to Wnts. Thus Wnt can-
not inhibit GSK-3β facilitating tau hyperphosphorylation and
NFT formations, leading to neurotoxicity and apoptosis caused
by Aβ peptides (Caricasole et al., 2004). The use of an antibody
antiDkk-1 also blocks the synaptic loss induced by Aβ (Purro
et al., 2012). In the same report, Purro et al. (2012) documented
that Dkk-1 can reversibly reduce the amount of synaptic proteins
and the number of active presynaptic sites, by inducing synaptic
disassembly at pre- and postsynaptic sites and not by degrading
proteins.
Recently, new evidence supports a link between Aβ toxicity
and the Wnt pathway. Aβ substantially increases the intracel-
lular protein clusterin, which induces Dkk-1 expression (Killick
et al., 2012). The C-terminal of the Dkk-1 protein, which antag-
onizes canonical Wnt pathway binding LRP5/6, later activates
gene transcription involved in AD-like pathology (Killick et al.,
2012). Because Dkk-1 blocks Wnt/β-catenin, Dkk-1 activates the
Wnt/JNK pathway, as has been shown from the increase in c-Jun
activity (Killick et al., 2012). Thus, the transcriptional Aβ effects
occur because Dkk-1 activates Wnt/JNK pathway. Clusterin has
been recently identiﬁed as a susceptibility factor in late-onset AD
(Harold et al., 2009; Lambert et al., 2009) and several genes from
Wnt/JNK have been found in the AD human brain (Killick et al.,
2012).
Synaptic failure is an early event in AD, and soluble Aβ
oligomers are proposed to be responsible for the synaptic pathol-
ogy that occurs before the plaque deposition and neuronal death
(Serrano-Pozo et al., 2011). Electrophysiological analysis of Schaf-
fer collaterals-CA1 glutamatergic transmission in hippocampal
slices demonstrated thatWnt5a prevents the decrease in the ampli-
tude of fEPSP and EPSCs induced byAβ oligomers, indicating that
Wnt5a prevents the synaptic damage triggered by Aβ (Cerpa et al.,
2010). Moreover, Wnt5a prevents the decreases in PSD-95 and
synaptic loss in cultured hippocampal neurons (Farias et al., 2009)
(Cerpa et al., 2010), supporting that Wnt5a improves synaptic
function in the presence of Aβ.
Several studies have shown neuroprotective properties of the
Wnt signaling activation against the toxicity of Aβ peptide
(Figure 4). The protective effect of Wnt3a against the toxicity
of Aβ oligomers was shown to be mediated by the Wnt Fz1 recep-
tor, since this effect is modulated by the expression levels of Fz1 in
both, PC12 cells and hippocampal neurons (Chacon et al., 2008).
Overexpression of Fz1 signiﬁcantly increased cell survival induced
by Wnt3a and diminished caspase-3 activation, while knocking-
down the expression of the receptor by antisense oligonucleotides
decreased the stabilization of β-catenin induced by Wnt3a and
decreases the neuroprotective effect elicited by this Wnt ligand
(Chacon et al., 2008). These studies support the evidence that
alterations in Wnt/β-catenin are involved in AD.
One of the hallmarks of AD brains is the abnormal phospho-
rylation of the tau protein which accumulates as intraneuronal
NFT (Serrano-Pozo et al., 2011). Cultured neurons exposed to
Aβ show an increase in GSK-3β activity (Takashima et al., 1993;
Alvarez et al., 2004; Inestrosa et al., 2005). Importantly, active
Frontiers in Cellular Neuroscience www.frontiersin.org July 2013 | Volume 7 | Article 103 | 7
“fncel-07-00103” — 2013/7/3 — 14:52 — page 8 — #8
Rosso and Inestrosa Wnt in CNS development and functioning
FIGURE 4 |Wnt ligands protect neurons from the toxic effects of Aβ
Oligomers.The scheme illustrates the neurotoxic effect of Aβ oligomers on
neurons which became dystrophic showing neurite fragmentation and
eventual cell death. However, in the presence of a canonical Wnt ligand,
neurons became neuroprotected and no neuropathological changes are
evident. The immunoﬂuorescence photographs presented below, were
taken against the GFP expressing protein present in hippocampal neurons
incubated under different conditions: (1) control conditions, (2) Aβ
oligomers, and (3) Aβ oligomers plusWnt7a. In the presence of Aβ
oligomers, treated neurons showed typical neurodegenerative alterations
including loss of somatodendritic arborization and neurite fragmentation.
After co-incubation withWnt7a, the neurotoxic effect of Aβ oligomers is not
longer present, and hippocampal neurons look pretty normal.
GSK-3β has been found in brains staged for AD neuroﬁbrillary
changes with a concomitant decreases in β-catenin levels and an
increase in tau hyperphosphorylation (Pei et al., 1999). Also, neu-
rodegeneration and spatial learning deﬁcits have been observed
in GSK-3β conditional transgenic mice (Lucas et al., 2001; Her-
nandez et al., 2002). Moreover, over-expression of GSK-3β in
mice prevents the induction of LTP and reduces spatial learn-
ing (Hernandez et al., 2002; Hooper et al., 2007), linking the
characteristic memory failure in AD to the increase in GSK-
3β. In cultured neurons the toxicity mediated by Aβ depends
on increased GSK-3 activity, and reverses when GSK-3β expres-
sion or activity is blocked (Busciglio et al., 1995; Alvarez et al.,
1999). We previously demonstrated that activation of Wnt sig-
naling inhibits GSK-3β and leads to neuroprotection in both
hippocampal cultured neurons and in vivo transgenicmodel of AD
(Alvarez et al., 2004; Quintanilla et al., 2005; Toledo and Inestrosa,
2010). Moreover, Li et al. (2007) found that tau phosphoryla-
tion, which inhibits competitive phosphorylation of β-catenin
by GSK-3β, protects neurons from apoptosis. This results sup-
port a role of β-catenin as a survival element in AD. Finally, the
activation of several signaling pathways that crosstalk with the
Wnt pathway, including the nicotinic and muscarinic ACh recep-
tors, peroxisome proliferator-activated receptor (PPAR) α and γ,
anti-oxidants, and anti-inﬂammatory pathways, all support the
neuroprotective potential of the Wnt cascades in AD (Inestrosa
and Toledo, 2008; Inestrosa and Arenas, 2010; Inestrosa et al.,
2012).
CONCLUSION
This review focused on the role of Wnt proteins on neuronal
development and their participation on the synaptic function.
Wnt signaling regulates neuronal maturation by stimulation of
dendrite formation and complexity. Particularly, it has been
reported that neurons exposed to Wnt elicit longer dendrites
and more complex dendritic branches. In addition, several works
have demonstrated that the non-canonical Wnt pathways would
modulate dendrite formation. Thus, Wnt effectors as JNK and
CaMKII may control dendrite architecture and neuronal matu-
ration (Threadgill et al., 1997; Rosso et al., 2005; Wayman et al.,
2006). Importantly, these effectors have been implicated in
cytoskeletal remodeling by controllingMAPsphosphorylation and
microtubule dynamics and, they also bind and modulate actin
ﬁlopodia extension (Shen et al., 1998; Chang et al., 2003; Fink
et al., 2003; Bjorkblom et al., 2005). Changes in the organiza-
tion and stability of cytoskeletal components by Wnt pathways
likely affect dendritic growth and dynamics. Furthermore, neu-
ronal activity plays a central role in dendrites formation and
maintenance. Several studies have shown that the stimulation of
neuronal activity leads to increase the expression and/or secre-
tion of Wnt proteins and also can modify the MAPs activity
and microtubule stability (Vaillant et al., 2002; Yu and Malenka,
2003; Wayman et al., 2006). Dendrites morphologies inﬂuence
on synaptic function and neuronal circuits formation. Thus,
the timing of synapse formation coincides with the period of
dendritic growth and branching. A great body of evidences exten-
sively suggests that Wnt signaling modulate synaptic function and
plasticity. Thus, the pre- and postsynaptic terminal assembly is
modulated by Wnt signaling to maintain the central connectiv-
ity (Hall et al., 2000; Packard et al., 2002; Ahmad-Annuar et al.,
2006; Cerpa et al., 2008; Henriquez et al., 2008; Farias et al., 2009;
Cuitino et al., 2010). Taken together, these compiled ﬁndings
provide important insights about the involvement of Wnt sig-
naling pathways on the formation and functioning of neuronal
circuits.
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